Skip to content
-
Ensuring Rebates and Discounts in Medicare Part D Help Reduce Patient OOP Costs
Oct 05, 2017
Please click here for the final signed copy of the letter Rep. Buddy Carter championed and... read more
-
National Association of Specialty Pharmacy Dismisses PBM-Funded Report Claiming Drug Cost Savings from Direct & Indirect Remuneration (DIR) Fees
Aug 04, 2017
View Press Release DIR fees continue to inflate prescription drug costs for the sickest, most vulnerable... read more
-
NASP Applauds CMS for Enhancing Oversight & Holding Large Pharmacy Benefit Managers Accountable for Rising Drug Costs
Jun 20, 2017
FOR IMMEDIATE RELEASE View Press Release National Association of Specialty Pharmacy Applauds CMS for Enhancing Oversight... read more
-
NASP’s comments to CMS’ Proposed Medicare Part D DIR Reporting Requirements for 2016
Jun 02, 2017
NASP represents an industry that focuses on providing quality patient care first with an added emphasis... read more
-
NASP White Paper: “Performance” Based DIR Fees: A Rigged System with Disparate Effect on Specialty Pharmacies, Medicare Part D Beneficiaries and the U.S. Healthcare System
Mar 20, 2017
On behalf of National Association of Specialty Pharmacy, the Executive Board commissioned a white paper (Performance”... read more
-
NASP Response to Centers for Medicare & Medicaid Services (CMS) Comments Regarding Draft 2018 Call Letter
Mar 10, 2017
NASP represents an industry that focuses on providing quality patient care first with an added emphasis... read more
-
NASP’s Response Advance Notice of Methodological Changes for Calendar Year (201) for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 201 Call Letter
Mar 04, 2017
The National Association of Specialty Pharmacy (NASP) appreciatesthis opportunity to submit comments on the Centers for... read more
-
NASP’s Comments on HHS’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; Request for Information
Feb 16, 2017
The National Association of Specialty Pharmacy (NASP) represents the entire spectrum of the specialty pharmacy industry... read more
-
Advocacy Documents
Feb 10, 2017
Any Willing Pharmacy (AWP) Changes Are Needed to Improve Beneficiary Access to Specialty Pharmacies Overview of... read more
-
New Report from the Centers for Medicare and Medicaid Services (CMS) Illustrates the Challenges Associated with Direct and Indirect Remuneration (DIR) Fees
Jan 24, 2017
View Press Release The report validates the position of many industry experts that these fees,... read more